Correction: Clinical features and associated factors of intraocular inflammation following intravitreal brolucizumab as switching therapy for neovascular age‑related macular degeneration
Cite this article
Sotani, R., Matsumiya, W., Kim, K.W. et al. Correction: Clinical features and associated factors of intraocular inflammation following intravitreal brolucizumab as switching therapy for neovascular age‑related macular degeneration.
Graefes Arch Clin Exp Ophthalmol 262, 671 (2024). https://doi.org/10.1007/s00417-023-06339-z
Download citation
Published: 14 December 2023
Issue Date: February 2024
DOI: https://doi.org/10.1007/s00417-023-06339-z
Share this article
Anyone you share the following link with will be able to read this content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Comments (0)